Table 2. Sample characteristics by country.
Sample Characteristics | Ghana (%) | Kenya (%) | Uganda (%) | Zambia (%) | Total (%) |
---|---|---|---|---|---|
Sample Size | 379 (31.4) | 517 (42.8) | 262 (21.7) | 50 (4.1) | 1208 (100) |
Smear Grade | |||||
1+ | 72 (19.0) | 174 (33.7) | 21 (8.0) | 15 (30.0) | 282 (23.3) |
2+ | 62 (16.4) | 141 (27.3) | 131 (50.0) | 18 (36.0) | 352 (29.1) |
3+ | 245 (64.6) | 202 (39.1) | 110 (42.0) | 17 (34.0) | 574 (47.5) |
Stain Typea | |||||
Ziehl Neelsen | 379 (100) | 0 | 49 (18.7) | 0 | 428 (35.4) |
Kinyoun | 0 | 341 (66.0) | 0 | 50 (100) | 391 (32.4) |
Auramine/Rhodamine | 0 | 176 (34.0) | 207 (79.0) | 0 | 383 (31.7) |
Unknown | 0 | 0 | 6 (2.3) | 0 | 6 (0.5) |
Treatment Status | |||||
New case | 172 (45.4) | 352 (68.1) | 221 (84.4) | 0 | 745 (61.7) |
Follow Up | 0 | 124 (24.0) | 35 (13.4) | 0 | 158 (13.1) |
Retreatment | 0 | 38 (7.4) | 4 (1.5) | 0 | 43 (3.6) |
Unknown | 207 (54.6) | 3 (0.6) | 2 (0.8) | 50 (100) | 262 (21.7) |
aStain type specified in this table is the original type of stain used on the smear at the clinical site where sample was collected.